WALK101 Raises MYSC Seed Investment and is Selected for TIPS
Through TIPS selection, WALK101's technological prowess and commercialization capabilities have been officially validated, and we will accelerate product enhancement and global expansion.
Hello, this is the WALK101 Newsletter.
In this issue, we share the news that WALK101 attracted seed investment from MYSC and was selected for TIPS (Tech Incubator Program for Startup), a government technology startup support program. Beyond the level of 'Medical AI can become technology', it is important to build development, verification, and operation systems together so that it can be introduced to actual fields. This achievement is very meaningful as WALK101 was comprehensively evaluated for those requirements.
What TIPS Selection Means
TIPS focuses on linking private investment with government R&D to support tech startups. It verifies technological competitiveness, commercialization, and execution capabilities comprehensively.
- ► Technological verification: Identifying problems needed in the clinical field and providing measurement/analysis results tailored to the hospital environment
- ► Commercialization capability: Actually designing the adoption format and operational model tailored to the hospital environment (SaaS/On-prem/PACS integration)
- ► Extensibility evaluation: Presenting growth strategies including the expansion of the analysis pipeline by body part and roadmap to enter overseas markets
Competitiveness Recognized in Comprehensive Evaluation
This evaluation is meaningful because it is not a single item but the result of comparing the technology and commercialization readiness of several companies under the same standards. WALK101's strength lay in preparing from the perspective of 'medical device-level operation', including regulations, quality, and security, centered on GMSM, an AI-based X-ray image analysis software.
Next Step for WALK101
With this TIPS selection, WALK101 will fast-track executions leading not only to 'technology development' but also to 'field adoption'. Along with product advancement, we will strengthen the experience of natural usage within hospital workflows (PACS/EMR) and expand market verification based on global partnerships.
- ► Product Advancement: GMSM pipeline expansion and performance/stability improvements
- ► Adoption Acceleration: Expanding the scope of workflow application centered on PACS Integration
- ► Global Expansion: Formulating collaboration and verifying requirements through overseas exhibitions and partner meetings